Skip to content
Tech News
← Back to articles

Eli Lilly’s Experimental Pill Could Help You Ditch GLP-1 Obesity Shots, Trial Finds

2025-12-18 | original
read original get GLP-1 → more articles

People who switched from semaglutide or tirzepatide to orforglipron largely maintained their weight loss.

Explore topics: largely largely maintained loss maintained maintained weight
Related:
Glossier is closing most of its stores, joins list of DTC brands that are scaling back on physical locations
Why Liability Insurance No Longer Works the Way You Think — and What CEOs Must Do About It
Xbox Cofounder Is Secretly Working on an Amazon Phone
FDA approves higher-dose version of Wegovy shots
Python Blood Could Kickstart the Next Big Thing in Weight Loss

© 2026 GoKawiil

About | Editorial Policy | Contact